NCT04375722 Transcranial Alternating Current Stimulation (tACS) in Aphasia
| NCT ID | NCT04375722 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical College of Wisconsin |
| Condition | Aphasia |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2020-01-04 |
| Primary Completion | 2030-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2020-01-04 with a primary completion date of 2030-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will assess the effects of transcranial alternating current stimulation (tACS) on language recovery after stroke as well as healthy language functions.
Eligibility Criteria
Inclusion Criteria: Healthy Controls * 18 years of age or older * Fluent in English * No history of neurological or psychiatric disorders Stroke Patients * Diagnosed with post-stroke aphasia by referring physician/neuropsychologist * Consent date \>=1 months after stroke onset * Right-handed * Fluent in English * 18 years of age or older Exclusion Criteria: * Severe cognitive, auditory or visual impairments that would preclude cognitive and language testing * Presence of major untreated or unstable psychiatric disease * A chronic medical condition that is not treated or is unstable * The presence of cardiac stimulators or pacemakers * Any metal implants in the skull * Contraindications to MRI or tACS * History of seizures * History of dyslexia or other developmental learning disabilities
Contact & Investigator
Priyanka Shah-Basak, PhD
PRINCIPAL INVESTIGATOR
Medical College of Wisconsin
Frequently Asked Questions
Who can join the NCT04375722 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Aphasia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04375722 currently recruiting?
Yes, NCT04375722 is actively recruiting participants. Contact the research team at sschoenrock@mcw.edu for enrollment information.
Where is the NCT04375722 trial being conducted?
This trial is being conducted at Milwaukee, United States.
Who is sponsoring the NCT04375722 clinical trial?
NCT04375722 is sponsored by Medical College of Wisconsin. The principal investigator is Priyanka Shah-Basak, PhD at Medical College of Wisconsin. The trial plans to enroll 50 participants.